Nkarta Investor Relations Material
Latest events
FDA Announcement
Nkarta
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Nkarta Inc
Access all reports
Nkarta Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel allogeneic, off-the-shelf engineered natural killer (NK) cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Nkarta Inc
Corporate Presentation
Nkarta Inc
Corporate Presentation
Nkarta Inc
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
NKTX
Country
🇺🇸 United States